| NCT01427842 | Vancomycin Therapy | Drug: DEVINE vancomycin regimen | The Canberra Hospital | Phase 2 | 2011-08-01 | 2011-09-01 |
| NCT02096536 | Neonatal Infection | Drug: Vancomycin | Universitaire Ziekenhuizen Leuven | Phase 4 | 2014-04-01 | 2015-11-02 |
| NCT01623817 | Infection | Drug: Vancomycin HCL | Samsung Medical Center | | 2012-06-01 | 2012-06-19 |
| NCT03046901 | Primary Sclerosing Cholangitis|Post- Orthotopic Liver Transplantation | Drug: Vancomycin | Ochsner Health System | | 2016-12-07 | 2017-02-07 |
| NCT01619982 | Congenital Heart Diseases|Aortic Valve Disorder | Drug: Cefazolin pre-operative prophylaxis|Drug: Vancomycin hydrochloride | Stanford University | Phase 4 | 2012-02-01 | 2016-02-04 |
| NCT02051595 | Infection | Other: Vancomycin concentrations | University of Florida | Early Phase 1 | 2014-04-01 | 2015-08-31 |
| NCT01322386 | Primary Sclerosing Cholangitis|Biliary Atresia | Drug: Vancomycin | Stanford University | Phase 1 | 2007-05-01 | 2016-04-18 |
| NCT02020031 | Arthropathy of Knee Joint | Drug: Vancomycin | Mayo Clinic|Vidacare Corporation | Phase 2|Phase 3 | 2013-12-01 | 2016-10-04 |
| NCT00861887 | Clostridium Difficile Colitis | Drug: Standard Vancomycin|Drug: Extended Vancomycin | William Beaumont Hospitals|Beaumont Hospital | | 2009-02-01 | 2016-12-13 |
| NCT02284126 | Infection|Surgery|Nervous System Diseases | Drug: Vancomycin | Columbia University|Agency for Healthcare Research and Quality (AHRQ)|Cornell University|Icahn School of Medicine at Mount Sinai | Phase 3 | 2014-10-01 | 2017-02-15 |
| NCT02631408 | Spinal Fusion Acquired | Drug: Vancomycin | Orthopedic Hospital Vienna Speising | Phase 4 | 2015-08-01 | 2016-09-26 |
| NCT01802073 | Primary Sclerosing Cholangitis | Drug: Oral Vancomycin | Stanford University | Phase 3 | 2012-01-01 | 2016-10-12 |
| NCT01509339 | Cystic Fibrosis|Methicillin-resistant Staphylococcus Aureus | Drug: Vancomycin | Case Western Reserve University|Cystic Fibrosis Foundation Therapeutics | Phase 1 | 2012-01-01 | 2013-01-25 |
| NCT02764359 | Infection|Sepsis|Obesity | Drug: IV vancomycin | CAMC Health System | | 2016-05-01 | 2016-06-20 |
| NCT01720940 | Infections Requiring Prolonged Duration (>10 Days) of Vancomycin | Drug: continuous vancomycin infusion|Drug: intermittent vancomycin infusion | National University Hospital, Singapore|Tan Tock Seng Hospital | | 2012-10-01 | 2012-11-01 |
| NCT01346059 | Colitis | Drug: Vancomycin|Drug: Saline | Marc Grodsky|William Beaumont Hospitals | | 2011-04-01 | 2012-09-15 |
| NCT02663596 | Pediatric Continuous Renal Replacement Therapy|Dialysis|Renal Failure | Drug: Vancomycin | Drexel University|The Center for Pediatric Pharmacotherapy, LLC | Phase 1 | 2017-01-01 | 2017-03-07 |
| NCT01786161 | MRSA - Methicillin Resistant Staphylococcus Aureus Infection | Drug: Vancomycin continuous infusion|Drug: Vancomycin intermittent dosing interval | Massachusetts General Hospital | Phase 4 | 2013-09-01 | 2016-11-30 |
| NCT02400112 | Fractures, Open|Surgical Wound Infection | Drug: Vancomycin | University of Tennessee | Phase 4 | 2015-03-01 | 2015-03-23 |
